Protalix
Protalix is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases.
Business Model:
Revenue: $47.6M
Employees: 51-200
Industries / Tags:
Detailed Protalix Information
Geographic Data
Address: 2 University Plaza
City: Hackensack
State: NJ
Zip: 07601
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$40M
Raised Total:$122M
Social
Metrics
4,653,506Website Global Rank
2,111Website Monthly Traffic
Twitter Followers
Description
Protalix is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases.
Contact Phone:
+12016969345
Contact Email:
Protalix went public on 11/11/2010 on the NYSE
Listed Exchange:
NYSE
IPO Date:
11/11/2010
Ticker Symbol:
PLX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
